- NYSE:KODK rises 5.24% after a renowned investment firm initiates a new position.
- Investors anticipate the federal loan being released and Kodak to begin supplying the U.S. with active pharmaceutical ingredients.
It has been a strange year for a multitude of reasons but not the least of which has been the sudden resurgence of Eastman Kodak (NYSE:KODK) as a stock to invest in again. Kodak made headlines after receiving a $765 million government loan from the Trump Administration in July to jumpstart domestic production of active pharmaceutical ingredients – some that were being planned to use in a potential coronavirus vaccine. Kodak shares spiked over 3000% on the news of the loan and the once-dormant photography stock was making headlines all over the investing world.
Since that surge, the stock has come back down to Earth falling over 90% since it reached its 52-week high of $60. News of insider training and dishonest executive decisions soured investors – especially after the loan was paused based on an SEC investigation into the company. Recently, renowned investor David Shaw of D.E. Shaw & Company has initiated a position in Kodak, giving investors the impression that shares may have reached their bottom. While trading at only 0.36x sales and with cash reserves equal to $2.83 per share – Shaw may have seen this as too cheap of an opportunity to pass up given the current climate.
KODK stock news
Even with Shaw’s investment, it is difficult to remain excited about shares of Kodak as inept ownership making bad decisions should always be a red flag to investors. There is an ongoing push from the Trump Administration to return pharmaceutical manufacturing back to US soil so as not to rely so heavily on China. The Federal election in November could have an effect on this sentiment and while shares of KODK could rise – they could just as easily return to obscurity.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
AUD/USD remains deep in the red below 0.6500 on US-China trade risks
AUD/USD remains under heavy selling pressure below 0.6500 in the Asian session on Tuesday, reversing some losses. Trump's threatened additional 10% tariffs on China, weighinmg heavily on risk sentiment and the China-proxy Australian Dollar while lifting the haven demand for the US Dollar.
USD/JPY extends its consolidative price move around 154.00
USD/JPY remains confined in a familiar range as traders seem reluctant amid mixed fundamental cues. The uncertainty over the timing and pace of interest rate hikes by the BoJ, the recent surge in the US bond yields and the risk-on mood undermine the JPY.
Gold rebounds from one-week low; finds support ahead of $2,600
Gold price dropped to a one-week low during the Asian session on Tuesday, albeit finds some support in the vicinity of the $2,600 mark. The prevalent risk-on environment, along with bets for slower Fed rate cuts and elevated US bond yields, drives flows away from the safe-haven XAU/USD and supports prospects for further losses.
Ripple's XRP eyes $1.96 after WisdomTree files for XRP ETF in the US
Ripple's XRP surged over 7% on Monday and aims to stage a rally toward its April 2021 high after WisdomTree registered for an XRP ETF in the US state of Delaware on Monday.
Eurozone PMI sounds the alarm about growth once more
The composite PMI dropped from 50 to 48.1, once more stressing growth concerns for the eurozone. Hard data has actually come in better than expected recently – so ahead of the December meeting, the ECB has to figure out whether this is the PMI crying wolf or whether it should take this signal seriously. We think it’s the latter.
Best Forex Brokers with Low Spreads
VERIFIED Low spreads are crucial for reducing trading costs. Explore top Forex brokers offering competitive spreads and high leverage. Compare options for EUR/USD, GBP/USD, USD/JPY, and Gold.